JANUS HENDERSON GROUP PLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$60,696,120
-13.2%
2,236,396
-1.7%
0.04%
-7.0%
Q2 2023$69,905,349
-24.3%
2,274,100
-11.3%
0.04%
-29.5%
Q1 2023$92,379,414
-10.1%
2,563,995
-1.4%
0.06%
-16.4%
Q4 2022$102,766,965
-7.6%
2,600,501
-53.0%
0.07%
-12.0%
Q3 2022$111,175,064
-14.9%
5,528,162
+77.9%
0.08%
-7.8%
Q2 2022$130,610,000
+20.5%
3,106,601
+11.6%
0.09%
+73.1%
Q1 2022$108,417,000
+5.9%
2,782,826
+8.3%
0.05%
+20.9%
Q4 2021$102,423,000
+20.0%
2,570,179
+8.8%
0.04%
+16.2%
Q3 2021$85,373,000
-44.4%
2,362,294
-36.9%
0.04%
-43.9%
Q2 2021$153,525,000
+183.8%
3,745,414
+202.0%
0.07%
+164.0%
Q1 2021$54,091,000
-78.0%
1,240,054
-74.7%
0.02%
-78.1%
Q4 2020$245,330,000
+23.4%
4,901,700
+3.7%
0.11%
+9.6%
Q3 2020$198,766,000
-9.2%
4,724,644
+4.8%
0.10%
-15.4%
Q2 2020$218,822,0004,507,1380.12%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2021
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders